Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients.

Saved in:
Bibliographic Details
Title: Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients.
Authors: Jelínek T; a Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine and Faculty of Science , University of Ostrava , Poruba , Czech Republic., Maisnar V; b 4th Department of Internal Medicine - Hematology, Charles University Faculty Hospital and Faculty of Medicine , Hradec Králové , Czech Republic., Pour L; c Department of Internal Medicine, Hematology and Oncology , University Hospital Brno and Faculty of Medicine Masaryk University , Jihlavská 340/20, 625 00 Brno-Bohunice-Brno-Starý Lískovec , Czech Republic., Špička I; d Department of Internal Medicine , Charles University in Prague, First Faculty of Medicine and General Teaching Hospital , Hradec Králové , Czech Republic., Minařík J; e Department of Hemato-Oncology , University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc , Olomouc , Czech Republic., Gregora E; f Department of Internal Medicine and Hematology , University Hospital Kralovske Vinohrady , Praha , Czech Republic., Kessler P; g Department of Hematology and Transfusion Medicine , Pelhrimov Hospital , Pelhřimov , Czech Republic., Sýkora M; h Department of Clinical Hematology , Hospital Ceske Budejovice , České Budějovice , Czech Republic., Fraňková H; i Department of Hematology , General Hospital Liberec , Liberec , Czech Republic., Adamová D; j Department of Clinical Hematology , Silesian Hospital Opava , Opava , Czech Republic., Wróbel M; k Department of Hematology , Hospital Novy Jicin , Nový Jičín , Czech Republic., Mikula P; l Department of Clinical Hematology , General Hospital Havirov , Havířov , Czech Republic., Jarkovský J; m Institute of Biostatistics and Analyses, Faculty of Medicine and Faculty of Science , Masaryk University , Brno , Czech Republic., Diels J; n Janssen Health Economics & Market Access EMEA Statistics & Modelling , Beerse , Belgium., Gatopoulou X; o Janssen Health Economics & Market Access EMEA , Athens , Greece., Veselá Š; p Janssen - Cilag s.r.o. , Smíchov-Anděl , Czech Republic., Besson H; n Janssen Health Economics & Market Access EMEA Statistics & Modelling , Beerse , Belgium., Brožová L; m Institute of Biostatistics and Analyses, Faculty of Medicine and Faculty of Science , Masaryk University , Brno , Czech Republic., Ito T; q Janssen Health Economics & Market Access EMEA , High Wycombe , UK., Hájek R; r Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine , University of Ostrava , Ostrava , Czech Republic.
Source: Current medical research and opinion [Curr Med Res Opin] 2018 May; Vol. 34 (5), pp. 775-783. Date of Electronic Publication: 2018 Feb 15.
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-4877 (Electronic) Linking ISSN: 03007995 NLM ISO Abbreviation: Curr Med Res Opin Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1473-4877
DOI:10.1080/03007995.2017.1410121